Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Trang T. Ly"'
Autor:
Daniel P. Howsmon, Faye Cameron, Nihat Baysal, Trang T. Ly, Gregory P. Forlenza, David M. Maahs, Bruce A. Buckingham, Juergen Hahn, B. Wayne Bequette
Publikováno v:
Sensors, Vol 17, Iss 1, p 161 (2017)
Reliable continuous glucose monitoring (CGM) enables a variety of advanced technology for the treatment of type 1 diabetes. In addition to artificial pancreas algorithms that use CGM to automate continuous subcutaneous insulin infusion (CSII), CGM ca
Externí odkaz:
https://doaj.org/article/29854c87b82d44cdaf0c90d057e0d467
Autor:
Georgia M. Davis, Anne L. Peters, Bruce W. Bode, Anders L. Carlson, Bonnie Dumais, Todd E. Vienneau, Lauren M. Huyett, Trang T. Ly
Publikováno v:
Diabetes Care. 46:742-750
OBJECTIVEAutomated insulin delivery (AID) has rarely been studied in adults with type 2 diabetes. We tested the feasibility of using AID for type 2 diabetes with the Omnipod 5 System in a multicenter outpatient trial.RESEARCH DESIGN AND METHODSPartic
Autor:
Grazia Aleppo, Daniel J. DeSalvo, Felipe Lauand, Lauren M. Huyett, Albert Chang, Todd Vienneau, Trang T. Ly
Publikováno v:
Diabetes Therapy. 14:593-610
Autor:
Daniel J. DeSalvo, Leslie Barrett, Trang T. Ly, Gregory P. Forlenza, Jennifer L. Sherr, Sue A. Brown, Alex Nguyen, Sheri L. Stone, Cari Berget, Ryan S. Kingman
Publikováno v:
Clinical Diabetes. 40:168-184
Automated insulin delivery (AID) systems, which connect an insulin pump, continuous glucose monitoring system, and software algorithm to automate insulin delivery based on real-time glycemic data, hold promise for improving outcomes and reducing ther
Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment
Autor:
Mei Mei Church, Brooke Narron, Trang T. Ly, Mary K. Voelmle, Lauren M. Huyett, Joon Bok Lee, Jordan E. Pinsker, Sue A. Brown, Bruce W. Bode, Jason O'Connor, Eric Benjamin, Bonnie Dumais
Publikováno v:
Diabetes Technology & Therapeutics
Background: Expert opinion guidelines and limited data from clinical trials recommend adjustment to bolus insulin doses based on continuous glucose monitor (CGM) trend data, yet minimal evidence exists to support this approach. We performed a clinica
Autor:
R. Daniel Pollom, Carol Wysham, Liza L. Ilag, Dana Sindelar, Yun Chen, Rattan Juneja, Trang T. Ly, Robert C. Hood
Publikováno v:
Endocrine Practice. 27:783-789
Objective We conducted a posthoc analysis of the VIVID study (Safety and Efficacy of Human Regular U-500 Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects With Type 2 Diabetes Mellitus: A Ra
Autor:
Amy Criego, Sarah A. Macleish, Jennifer L. Sherr, Jordan E. Pinsker, Ruth S. Weinstock, Anders L. Carlson, Anuj Bhargava, Richard M. Bergenstal, Thomas C. Jones, Daniel J. DeSalvo, Grazia Aleppo, Carol J. Levy, Bruce W. Bode, Sanjeev N. Mehta, Gregory P. Forlenza, Viral N. Shah, Bruce A. Buckingham, Irl B. Hirsch, David W Hansen, Sue A. Brown, Lori M. Laffel, Trang T. Ly
Publikováno v:
Diabetes Care
OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study of the first tubeless, on-body automated insulin delivery system with
Autor:
Aimee Grieme, Krista Kleve, Lauren M. Huyett, Cari Berget, Mary K. Voelmle, Bruce A. Buckingham, R. Paul Wadwa, Amy Criego, Laya Ekhlaspour, Ryan S. Kingman, Sue A. Brown, Bonnie Dumais, Grenye O’Malley, Gregory P. Forlenza, Jennifer Boyd, Robert J. Slover, Jason O'Connor, Carol J. Levy, Erin Cobry, Todd Vienneau, Laurel H. Messer, Kaisa Kivilaid, Bruce W. Bode, Joon Bok Lee, Eric Benjamin, Trang T. Ly, Susan McCoy
Publikováno v:
Diabetes Technology & Therapeutics
Background: The objective of this study was to assess the safety and effectiveness of the first commercial configuration of a tubeless automated insulin delivery system, Omnipod® 5, in children (6–13.9 years) and adults (14–70 years) with type 1
Autor:
Trang T. Ly, David W. Hansen, Sarah A. MacLeish, Daniel J. DeSalvo, Amy B. Criego, Bruce A. Buckingham, Melissa J. Schoelwer, Lori M. Laffel, Gregory P. Forlenza, Bruce W. Bode, Jennifer L. Sherr
Objective: Very young children with type 1 diabetes often struggle to achieve glycemic targets, putting them at risk of long-term complications and creating an immense management burden for caregivers. We conducted the first evaluation of the Omnipod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a059148f4bdfadbe531ac4ce3d2f75a9
https://doi.org/10.2337/figshare.19763350.v1
https://doi.org/10.2337/figshare.19763350.v1
Autor:
GEORGIA M. DAVIS, ANNE L. PETERS, BRUCE W. BODE, ANDERS L. CARLSON, BONNIE DUMAIS, TODD VIENNEAU, LAUREN M. HUYETT, TRANG T. LY
Publikováno v:
Diabetes. 71
As there is a pressing need for better treatment options for type 2 diabetes (T2D) , it is crucial to explore new technologies such as automated insulin delivery (AID) in this population. Little is known about how successful these systems will be in